trending Market Intelligence /marketintelligence/en/news-insights/trending/c5qk9d_p-fyeatsu6o3m6w2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Ampio Pharmaceuticals plans common stock, warrants offering

Video

Climate Credit Analytics: Linking climate scenarios to financial impacts

Blog

Global M&A Infographic Q1 2021

Blog

Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge

Blog

COVID-19 Impact & Recovery: Private Equity


Ampio Pharmaceuticals plans common stock, warrants offering

Englewood, Colo.-based Ampio Pharmaceuticals Inc. plans to sell its common shares and accompanying warrants to buy common shares in an underwritten public offering.

The clinical trial stage biopharmaceutical company will sell all of the securities in the proposed offering.

Net proceeds from the offering will be used for working capital and general corporate purposes, including continued preclinical development of Ampion and funding an Ampion clinical trial, if required.

Canaccord Genuity is acting as sole book-running manager for the proposed offering.